Hepatitis C virus (HCV)-induced cirrhosis is the most common indication for liver transplantation (LT). However, graft reinfection is nearly universal. The choice of immunosuppression, including the calcineurin inhibitor (CNI), may have some effect on severity of recurrence and graft survival. In ad
Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients
β Scribed by J. F. TROTTER; J. C. OSBORNE; M. HELLER; U. CHRISTIANS
- Book ID
- 108604113
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 128 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p
vival, and patient survival. We conclude that HCV geno-Infection with hepatitis C virus (HCV) genotype 1b type 1 and subtype 1b are not associated with disease has been reported to be associated with more severe severity or graft survival in liver transplantation recipiposttransplantation liver dise
The long-term effects of preemptive antiviral therapy on fibrosis progression in liver transplant recipients with hepatitis C virus (HCV) were examined in a cohort of consecutive liver transplant recipients who received preemptive antiviral therapy for 48 weeks (95% were virologic nonresponders). Co